Abstract
COVID-19 pandemic affected over 227 countries with more than 147 million infections that claimed 31.22 lacs lives. The first case of the pandemic was reported from China in Dec, 2019 showing pneumonia like symptoms that turned out to be the novel strain of coronavirus (2019-n- CoV). The WHO declared 2019-nCoV infection as the Public Health Emergency of International Concern and the disease named coronavirus disease (COVID-19). The infection curve of the pandemic has been flattened in many countries around the world, but the effective new antiviral drugs or vaccine has not yet developed. So far, we are saved by non-pharmaceutical interventions like handwashing, social distancing, quarantine, masks and health-care workers by personal protective equipments. Now the question arises that what we do if no effective drug or vaccine emerges? In the absence of effective drug/vaccines, pandemic has to be fought at community level not at hospitals. For such emergent situations, we need a ‘Plan B’ based non-vaccine/drug interventions.
Keywords: COVID-19, coronavirus (2019-n CoV), drug interventions, vaccine, immune system, non-drug/vaccine
Coronaviruses
Title:Controlling Coronavirus Infection: ‘Plan B’ Based on Non-vaccine / Drug Interventions
Volume: 2 Issue: 11
Author(s): Ram Kumar Dhaked*
Affiliation:
- Biotechnology Division, Defence Research & Development Establishment, Ministry of Defence, Govt. of India, Jhansi Road, Gwalior - 474002,India
Keywords: COVID-19, coronavirus (2019-n CoV), drug interventions, vaccine, immune system, non-drug/vaccine
Abstract: COVID-19 pandemic affected over 227 countries with more than 147 million infections that claimed 31.22 lacs lives. The first case of the pandemic was reported from China in Dec, 2019 showing pneumonia like symptoms that turned out to be the novel strain of coronavirus (2019-n- CoV). The WHO declared 2019-nCoV infection as the Public Health Emergency of International Concern and the disease named coronavirus disease (COVID-19). The infection curve of the pandemic has been flattened in many countries around the world, but the effective new antiviral drugs or vaccine has not yet developed. So far, we are saved by non-pharmaceutical interventions like handwashing, social distancing, quarantine, masks and health-care workers by personal protective equipments. Now the question arises that what we do if no effective drug or vaccine emerges? In the absence of effective drug/vaccines, pandemic has to be fought at community level not at hospitals. For such emergent situations, we need a ‘Plan B’ based non-vaccine/drug interventions.
Export Options
About this article
Cite this article as:
Dhaked Kumar Ram *, Controlling Coronavirus Infection: ‘Plan B’ Based on Non-vaccine / Drug Interventions, Coronaviruses 2021; 2 (11) : e310821191744 . https://dx.doi.org/10.2174/2666796702666210223155638
DOI https://dx.doi.org/10.2174/2666796702666210223155638 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
T-type Calcium Channels in Health and Disease
Current Medicinal Chemistry Comparing the Sensitivity and Specificity of Lung CT-scan with RT-PCR for Diagnosis of COVID-19
Current Medical Imaging Synthesis and Cytotoxicity of Enediyne Prodrugs with 3-Hydroxy-4- (arylmethylidene)cyclodeca-1,5-diyne Scaffolds
Letters in Drug Design & Discovery Inhibition of EGFR Signaling by N-cyclohexyl-2-(1-(phenylsulfonyl)piperidin-4-yl) acetamide
Anti-Cancer Agents in Medicinal Chemistry RNA Interference for Viral Infections
Current Drug Targets Structure-Based Virtual Screening for Defeating Drug Resistant Form of EGFR Protein
Combinatorial Chemistry & High Throughput Screening 4-Aminoquinoline Based Molecular Hybrids as Antimalarials: An Overview
Current Topics in Medicinal Chemistry G-Protein Coupled Receptors (GPCRs): A Comprehensive Computational Perspective
Combinatorial Chemistry & High Throughput Screening Molecular Mechanisms Mediating Nociceptin/Orphanin FQ Receptor Signaling, Desensitization and Internalization
Current Molecular Pharmacology Intracellular Fate of Peptide-Mediated Delivered Cargoes
Current Pharmaceutical Design Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the Literature
Current Pharmaceutical Design Lanthanides as Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents Arylurea Derivatives: A Class of Potential Cancer Targeting Agents
Current Topics in Medicinal Chemistry Structure-Based Design in the GPCR Target Space
Current Medicinal Chemistry A Review on Pharmacological Properties of Coumarins
Mini-Reviews in Medicinal Chemistry Structure-Activity Relationships of Histamine H2 Receptor Ligands+
Mini-Reviews in Medicinal Chemistry Improved Prediction of Lysine Acetylation by Support Vector Machines
Protein & Peptide Letters Combat Pneumococcal Infections: Adhesins as Candidates for Protein- Based Vaccine Development
Current Drug Targets Variation of pKa in the N-Terminal Tyrosine Side Chain in Octapeptide Analogs of Tendamistat Influences α-Amylase Inhibition
Protein & Peptide Letters From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications
Current Topics in Medicinal Chemistry